<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        3112246512
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2019
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        OBSOL 5 MG FILM COATED TABLET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        BISOPROLOL FUMARATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        16.25
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="UNITED PHARMACEUTICAL COMPANY" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            UNITED PHARMACEUTICAL COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            MS Pharma Saudi (MSPS)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C07AB07
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Pharmacotherapeutic group:</strong> The active substance in Obsol is bisoprolol. Bisoprolol belongs to a group of medicines called beta-blockers. These medicines work by affecting the body`s response to some nerve impulses, especially in the heart. As a result, bisoprolol slows down the heart rate and<br />makes the heart more efficient at pumping blood around the body.</p><p><strong>Therapeutic indications:</strong><br />Heart failure occurs when the heart muscle is weak and unable to pump enough blood to supply the body&rsquo;s needs. Obsol is used to treat stable chronic heart failure.<br />It is used in combination with other medicines suitable for this condition (such as ACEinhibitors, diuretics, and heart glycosides).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>a. Do not take Obsol</strong><br />Do not take Obsol if one of the following conditions applies to you:<br />-Allergy (hypersensitivity) to bisoprolol or to any of the other ingredients.<br />-Severe asthma<br />-Severe blood circulation problems in your limbs (such as Raynaud&rsquo;s syndrome), which may cause your fingers and toes to tingle or turn pale or blue<br />-Untreated phaeochromocytoma, which is a rare tumour of the adrenal gland<br />-Metabolic acidosis, which is a condition when there is too much acid in the blood.</p><p><em>Do not take Obsol if you have one of the following heart problems:</em><br />-Acute heart failure<br />-worsening heart failure requiring injection of medicines into a vein, that increase the force of contraction of the heart<br />-Slow heart rate<br />-Low blood pressure<br />-Certain heart conditions causing a very slow heart rate or irregular heartbeat<br />-Cardiogenic shock, which is an acute serious heart condition causing low blood pressure and circulatory failure.</p><p><strong>b. Take special care with Obsol</strong><br />Talk to your doctor or pharmacist before taking Obsol</p><p>If you have any of the following conditions tell your doctor before taking Obsol; he or she may want to take special care (for example give additional treatment or perform more frequent checks):<br />-Diabetes<br />-Strict fasting<br />-Certain heart diseases such as disturbances in heart rhythm, or severe chest pain at rest (Prinzmetal&rsquo;s angina)<br />-Kidney or liver problems<br />-Less severe blood circulation problems in your limbs<br />-Chronic lung disease or less severe asthma<br />-History of a scaly skin rash (psoriasis)<br />-Tumour of the adrenal gland (phaeochromocytoma)<br />-Thyroid disorder.</p><p><br /><em>In addition, tell your doctor if you are going to have:</em><br />-Desensitization therapy (for example for the prevention of hay fever), because Obsol may make it more likely that you experience an allergic reaction, or such reaction may be more severe<br />-Anaesthesia (for example for surgery), because Obsol may influence how your body reacts to this situation.<br />If you have chronic lung disease or less severe asthma please inform your doctor immediately<br />if you start to experience new difficulties in breathing, cough, wheezing after exercise, etc. when using Obsol.</p><p><em>Children and adolescents</em><br />Obsol is not recommended for use in children or adolescents</p><p><strong>c. Taking other medicines, herbal or dietary supplements</strong><br />Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.<br />Do not take the following medicines with Obsol without special advice from your doctor:<br />-Certain medicines used to treat irregular or abnormal heartbeat (Class I antiarrhythmic medicines such as quinidine, disopyramide, lidocaine, phenytoin; flecainide, propafenone)<br />-Certain medicines used to treat high blood pressure, angina pectoris or irregular heartbeat (calcium antagonists such as verapamil and diltiazem)<br />-Certain medicines used to treat high blood pressure such as clonidine, methyldopa, moxonodine, rilmenidine.</p><p>However, do not stop taking these medicines without checking with your doctor first.<br />Check with your doctor before taking the following medicines with Obsol; your doctor may need to check your condition more frequently:<br />&bull; Certain medicines used to treat high blood pressure or angina pectoris (dihydropyridinetype calcium antagonists such as felodipine and amlodipine)<br />-Certain medicines used to treat irregular or abnormal heartbeat (Class III antiarrhythmic medicines such as amiodarone)<br />-Beta-blockers applied locally (such as timolol eye drops for glaucoma treatment)<br />-Certain medicines used to treat for example Alzheimer&rsquo;s disease or glaucoma (parasympathomimetics such as tacrine or carbachol) or medicines that are used to treat acute heart problems (sympathomimetics such as isoprenaline and dobutamine)<br />-Antidiabetic medicines including insulin<br />-Anaesthetic agents (for example during surgery)<br />-Digitalis, used to treat heart failure<br />-Non-steroidal anti-inflammatory medicines (NSAIDs) used to treat arthritis, pain or inflammation (for example ibuprofen or diclofenac)<br />-Any medicine, which can lower blood pressure as a desired or undesired effect such as<br />-antihypertensives, certain medicines for depression (tricyclic antidepressants such as imipramine or amitriptyline), certain medicines used to treat epilepsy or during anaesthesia&nbsp;(barbiturates such as phenobarbital), or certain medicines to treat mental illness characterized by a loss of contact with reality (phenothiazines such as levomepromazine)<br />-Mefloquine, used for prevention or treatment of malaria<br />-Depression treatment medicines called monoamine oxidase inhibitors (except MAO-B inhibitors) such as moclobemide.</p><p><strong>d. Taking Obsol with food and drink</strong><br />Take the tablet with some water in the morning, with or without food.</p><p><strong>e. Pregnancy and breast-feeding</strong><br />Pregnancy:<br />There is a risk that use of Obsol during pregnancy may harm the baby. If you are pregnant or planning to become pregnant, tell your doctor. He or she will decide whether you can take Obsol during pregnancy.</p><p>Breast-feeding:<br />It is not known whether bisoprolol passes into human breast milk. Therefore, breastfeeding<br />is not recommended during therapy with Obsol.</p><p><strong>f. Driving and using machines</strong><br />Your ability to drive or use machinery may be affected depending on how well you tolerate the medicine.<br />Please be especially cautious at the start of treatment, when the dose is increased or the medication is changed, as well as in combination with alcohol.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.<br />Obsol is taken orally.</p><p>Dosage and administration:<br />Treatment with Obsol requires regular monitoring by your doctor. This is particularly necessary at the start of treatment, during dose increase and when you stop treatment.<br />Take the tablet with some water in the morning, with or without food. Do not crush or chew the tablet. The scored tablets can be divided into two equal doses.</p><p>Treatment with Obsol is usually long-term.</p><p>Adults including the elderly:<br />Treatment with bisoprolol must be started at a low dose and increased gradually.<br />Your doctor will decide how to increase the dose, and this will normally be done in the following way:<br />-1.25 mg bisoprolol once daily for one week<br />-2.5 mg bisoprolol once daily for one week<br />-3.75 mg bisoprolol once daily for one week<br />-5 mg bisoprolol once daily for four weeks<br />-7.5 mg bisoprolol once daily for four weeks<br />-10 mg bisoprolol once daily for maintenance (ongoing) therapy.</p><p>The maximum recommended daily dose is 10 mg bisoprolol.</p><p>Depending on how well you tolerate the medicine, your doctor may also decide to lengthen the time between dose increases. If your condition gets worse or you no longer tolerate the drug, it may be necessary to reduce the dose again or to interrupt treatment. In some patients a maintenance dose lower than 10 mg bisoprolol may be sufficient.</p><p>Your doctor will tell you what to do.</p><p>If you have to stop treatment entirely, your doctor will usually advise you to reduce the dose gradually, as otherwise your condition may become worse.</p><p><strong>a. If you take more Obsol than you should</strong><br />If you have taken more Obsol tablets than you should, tell your doctor immediately. Your doctor will decide what measures are necessary. Symptoms of an overdose may include slowed heart rate, severe difficulty in breathing, feeling dizzy, or trembling (due to decreased blood sugar).</p><p><strong>b. If you forget to take Obsol</strong><br />Do not take a double dose to make up for a forgotten dose. Take your usual dose the next morning.<br />If you stop taking Obsol<br />Never stop taking Obsol unless on your doctor&rsquo;s advice. Otherwise your condition could become much worse.<br />If you have any further questions on the use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.<br />To prevent serious reactions, speak to a doctor immediately if a side effect is severe, occurred suddenly or gets worse rapidly.</p><p>The most serious side effects are related to the heart function:<br />&bull;Slowing of heart rate (may affect more than 1 in 10 people)<br />&bull;Worsening of heart failure (may affect up to 1 in 10 people)<br />&bull;Slow or irregular heartbeat (may affect up to 1 in 100 people)</p><p>If you feel dizzy or weak, or have breathing difficulties please contact your doctor as soon as possible.<br />Further side effects are listed below according to how frequently they may occur:<br /><strong>Common (may affect up to 1 in 10 people):</strong><br />&bull;Tiredness, feeling weak, dizziness, headache<br />&bull;Feeling of coldness or numbness in hands or feet<br />&bull;Low blood pressure<br />&bull;Stomach or intestine problems such as nausea, vomiting, diarrhoea, or constipation.</p><p><strong>Uncommon (may affect up to 1 in 100 people):</strong><br />&bull;sleep disturbances<br />&bull;Depression<br />&bull;Dizziness when standing up<br />&bull;breathing problems in patients with asthma or chronic lung disease<br />&bull;Muscle weakness, muscle cramps.</p><p><strong>Rare (may affect up to 1 in 1,000 people):</strong><br />&bull;Hearing problems<br />&bull;Allergic runny nose<br />&bull;Reduced tear flow<br />&bull;Inflammation of the liver which can cause yellowing of the skin or whites of the eyes<br />&bull;Certain blood test results for liver function or fat levels differing from normal<br />&bull;Allergy-like reactions such as itching, flush, rash<br />&bull;Impaired erection<br />&bull;Nightmares, hallucinations<br />&bull;Fainting.<br />Very rare (may affect up to 1 in 10,000 people):<br />&bull;Irritation and redness of the eye (conjunctivitis)<br />&bull;Hair loss<br />&bull;Appearance or worsening of scaly skin rash (psoriasis); psoriasis-like rash.</p><p>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, health care provider or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- Keep out of the reach and sight of children.<br />- Do not store above 30&deg;C.<br />- Do not use Obsol after the expiry date (Exp. Date) which is stated on the outer pack. The expiry date refers to the last day of that month.<br />- Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is: Bisoprolol Fumarate.<br />Obsol 5mg F.C. Tablets: Each film coated tablet contains Bisoprolol Fumarate 5 mg.<br />Obsol 10mg F.C. Tablets: Each film coated tablet contains Bisoprolol Fumarate 10 mg.<br />Hospital packs are also available<br />The other ingredients are for:<br />Obsol 5mg F.C. Tablets: Dibasic Calcium phosphate, Microcrystalline cellulose, Maize Starch,<br />Crospovidone, Magnesium Stearate, Hydroxypropyl methylcellulose, Yellow iron oxide.<br />Obsol 10mg F.C. Tablets: Dibasic Calcium phosphate, Microcrystalline cellulose, Maize<br />Starch, Crospovidone, Magnesium Stearate, Hydroxypropyl methylcellulose, Red iron<br />oxide, Yellow iron oxide.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Film coated tablets.
Physical Description:
Obsol 5mg F.C. Tablets: Heart-shaped beige biconvex film coated tablet, embossed with “I 42” and scored at the both side.
Obsol 10mg F.C. Tablets: Heart-shaped light brown film coated tablets embossed with “T 32” and scored at the both sides.
Obsol F.C. Tablets: are packed in Aluminum & PVC/PE /PVDC Rolls then packed in cardboard cartons with a folded leaflet.
Pack size: 30 F/C Tablets; (10 F/C Tablets /blister, 3 blisters/ pack).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing authorization holder:<br />MS Pharma Saudi</p><p>Riyadh, Kingdome Saudi Arabia.<br />info-ksa@mspharma.com</p><p><br />Manufacturer by<br />United Pharmaceutical Mfg. Co. Ltd. - Jordan for MS Pharma-Saudi.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                 Feb/2020; version number: SPM190336
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p style="direction: rtl;">:المجموعة الدوائية</p><p style="direction: rtl;">المادة الفعالة هي بيسوبرولول فيوماريت. ينتمي بيسوبرولول إلى مجموعة من الأدوية تسمى حاصرات مستقبلات بيتا. تحمي هذه الأدوية القلب ضد الكثير من النشاط. هذه الأدوية تعمل من خلال التأثير على استجابة الجسم لبعض النبضات العصبية، وخاصة في القلب. ونتيجة لذلك، يخفض بيسوبرولول من معدل ضربات القلب ويجعل القلب أكثر كفاءة في ضخ الدم في جميع أنحاء الجسم</p><p style="direction: rtl;">:الاستعمالات العلاجية</p><p style="direction: rtl;">يحدث فشل القلب عندما تضعف عضلة القلب وتكون غير قادرة على ضخ ما يكفي من الدم لتوفير احتياجات الجسم. يستخدم اوبسول&nbsp; لعلاج قصور القلب المزمن المستقر</p><p style="direction: rtl;">يتم استخدامه بشكل متزامن مع أدوية أخرى مناسبة لهذه الحالة (مثل مثبطات الإنزيم المحول لأنجيوتنسين، مدرات البول، وجليكوسيدات القلب)</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>أ. موانع استعمال اوبسول&nbsp;</strong></p><p>لا تأخذ اوبسول&nbsp; إذا كان أحدى الحالات التالية تنطبق عليك</p><p>الحساسية (فرط الحساسية) لمادة اوبسول ول أو لأي من المكونات الأخرى</p><p>ربو شديد</p><p>مشاكل حادة في الدورة الدموية في الأطراف (مثل متلازمة رينود)، مما قد يتسبب في خدران، شحوب أو ازرقاق أصابع اليدين والقدمين</p><p>ورم القواتم غير المعالج، وهو ورم نادر يصيب الغدة الكظرية</p><p>الحماض الأيضي، وهو تراكم مفرط للحمض في الجسم</p><p>لا تأخذ اوبسول&nbsp; إذا كانت تعاني من واحد من مشاكل القلب التالية</p><p>قصور القلب الحاد</p><p>تفاقم فشل القلب والذي يتطلب حقن الأدوية في الوريد، التي تزيد من قوة انقباض القلب</p><p>بطء معدل ضربات القلب</p><p>انخفاض ضغط الدم</p><p>بعض أمراض القلب مما تسبب في تباطأ معدل ضربات القلب أو عدم انتظام ضربات القلب</p><p>صدمة قلبية، وهي حالة الحاد خطيرة بالقلب مما تسبب انخفاض ضغط الدم وفشل في الدورة الدموية</p><p>&nbsp;</p><p><strong>ب. الاحتياطات عند استعمال اوبسول&nbsp;</strong></p><p>تحدث إلى طبيبك قبل تناول اوبسول&nbsp; إذا كنت</p><p>إذا كنت&nbsp;تعاني أي من الحالات التالية أخبر طبيبك قبل تناول اوبسول . انه أو انها قد تريد اتخاذ الرعاية الخاصة (على سبيل المثال منح معاملة إضافية أو تنفيذ اختبارات بشكل أكثر تواترا)</p><p>داء السكري</p><p>الصوم الصارم</p><p>&nbsp;بعض أمراض القلب مثل اضطرابات في ضربات القلب، أو آلام شديدة في الصدر أثناء الراحة (الذبحة الوعائية التشنجية)</p><p>&nbsp;مشاكل الكلى أو الكبد</p><p>مشاكل في الدورة الدموية أقل شدة في الأطراف الخاصة بك</p><p>مرض الرئة المزمن أو الربو الأقل حدة</p><p>&nbsp;تاريخ لحدوث طفح الجلد المتقشر (الصدفية)</p><p>&nbsp;أورام الغدة الكظرية (ورم القواتم)</p><p>اضطراب الغدة الدرقية</p><p>وبالإضافة إلى ذلك، أخبر طبيبك إذا كنت ستعاني من:</p><p>- علاج الحساسية (Desensitization) (على سبيل المثال للوقاية من حمى القش)، لأن اوبسول&nbsp; قد يجعلك من المرجح أن تعاني من الحساسية، أو رد فعل قد يكون أكثر شدة</p><p>&nbsp;التخدير (على سبيل المثال لعملية جراحية)، لأن اوبسول&nbsp; قد تؤثر على كيفية رد فعل الجسم لهذا الوضع</p><p>إذا كان لديك مرض الرئة المزمن أو الربو الأقل شدة، الرجاء إبلاغ الطبيب فورا إذا بدأت تواجه صعوبات جديدة في التنفس، سعال وصفير عند التنفس بعد التمارين، وما إلى ذلك عند استخدام اوبسول</p><p>&nbsp;</p><p><strong>الأطفال والمراهقين</strong></p><p>لا ينصح باستعمال اوبسول&nbsp; في الأطفال أو المراهقين</p><p>&nbsp;</p><p><strong>ج. التداخلات الدوائية من أخذ هذا المستحضر مع أي أدوية أخرى أو أعشاب أو مكملات غذائية</strong></p><p>أخبر طبيبك أو الصيدلاني إذا كنت تتناول أو تناولت مؤخرا أي أدوية أخرى</p><p>لا تأخذ الأدوية التالية مع اوبسول&nbsp; دون استشارة خاصة من طبيبك</p><p>بعض الأدوية المستخدمة لعلاج عدم انتظام ضربات القلب غير الطبيعي (المجموعة الأولى من الأدوية المضادة لاضطراب النظم مثل كينيدين، ديسوبيراميد، ليدوكائين، فينيتوين، فليكاينيد، بروبافينون)</p><p>بعض الأدوية المستخدمة لعلاج ارتفاع ضغط الدم، الذبحة الصدرية أو عدم انتظام ضربات القلب (مضادات الكالسيوم مثل فيراباميل وديلتيازيم)</p><p>بعض الأدوية المستخدمة لعلاج ارتفاع ضغط الدم مثل الكلونيدين، ميثيل دوبا، موكسونودين، ريلمينيدين</p><p>ومع ذلك، لا تتوقف عن تناول هذه الأدوية دون التحقق مع طبيبك أولا</p><p>استشر طبيبك قبل تناول الأدوية التالية مع اوبسول . طبيبك قد يحتاج إلى مراجعة حالتك بشكل متكرر أكثر</p><p>&nbsp;بعض الأدوية المستخدمة لعلاج ارتفاع ضغط الدم أو الذبحة الصدرية (ديهيدروبيريدين من نوع مضادات الكالسيوم مثل فيلوديبين وأملوديبين)</p><p>&nbsp;بعض الأدوية المستخدمة لعلاج عدم انتظام ضربات القلب غير الطبيعي (المجموعة الثالثة من الأدوية المضادة لاضطراب النظم مثل اميودارون)</p><p>&nbsp;حاصرات مستقبلات بيتا المسخدمة موضعيا (مثل قطرات العين من تيمولول لعلاج الجلوكوما)</p><p>بعض الأدوية المستخدمة لعلاج مرض الزهايمر أو الجلوكوما مثلا (محاكيات الاودي مثل تاكرين أو كرباكول) أو الأدوية التي تستخدم لعلاج مشاكل القلب الحادة (محاكيات الودي مثل إيزوبرينالين والدوبوتامين)</p><p>الأدوية المضادة للسكري بما في ذلك الأنسولين</p><p>ادوية التخدير (على سبيل المثال أثناء الجراحة)</p><p>الديجيتال، وتستخدم لعلاج قصور القلب</p><p>الأدوية المضادة للالتهابات الاستيرويدية (المسكنات) المستخدمة في علاج التهاب المفاصل، ألم أو التهاب (على سبيل المثال ايبوبروفين أو ديكلوفيناك)</p><p>أي دواء، والذي يمكن أن يخفض ضغط الدم كتأثير مطلوب أو غير مرغوب فيه مثل</p><p>خافضات ضغط الدم، وبعض الأدوية لعلاج الاكتئاب (مضادات الاكتئاب ثلاثية الحلقات مثل إيميبرامين أو أميتريبتيلين)، وبعض الأدوية المستخدمة في علاج الصرع أو أثناء التخدير (الباربيتورات مثل الفينوباربيتال)، أو بعض الأدوية لعلاج مرض عقلي يتميز بفقدان الاتصال مع الواقع (الفينوثيازين مثل ليفوميبرومازين)</p><p>&nbsp;المفلوكين، ويستخدم للوقاية أو علاج الملاريا</p><p>الأدوية التي تعالج الاكتئاب وتسمى مثبطات مونوامين أوكسيديز (باستثناء نوع ب) مثل موكلوبميد</p><p>&nbsp;</p><p><strong>د. تناول اوبسول&nbsp; مع الطعام والشراب</strong></p><p>يؤخذ القرص مع بعض الماء في الصباح، مع او دون الطعام</p><p>&nbsp;</p><p><strong>هـ. الحمل والرضاعة</strong></p><p>هناك خطر لاستخدام اوبسول&nbsp; أثناء الحمل قد يضر بالطفل. إذا كنت حاملا أو تخططين لتصبح حاملا، أخبري طبيبك. انه أو انها سوف تقرر ما إذا كنت يمكن أن تأخذي اوبسول&nbsp; خلال فترة الحمل</p><p>الرضاعة الطبيعية</p><p>من غير المعروف ما إذا كان بيسوبرولول يفرز في حليب الثدي البشري. لذلك، لا ينصح بالرضاعة الطبيعية خلال فترة العلاج مع اوبسول&nbsp;</p><p><strong>و. القيادة واستعمال الآلات</strong></p><p>قدرتك على القيادة أو استخدام الآلات قد تتأثر تبعا لكيفية تحمل الدواء</p><p>يرجى توخي الحذر خصوصا في بداية العلاج، وعندما يتم زيادة الجرعة أو يتم تغيير الأدوية، وكذلك مع تناوله مع الكحول</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>دائما تناول هذا الدواء تماما كما أخبرك طبيبك أو الصيدلاني. يجب التحقق من الطبيب أو الصيدلاني إذا كنت غير متأكد</p><p><strong>يؤخذ اوبسول&nbsp; عن طرق الفم</strong></p><p><strong>&nbsp;:الجرعة والاستعمال</strong></p><p>يتطلب العلاج مع اوبسول&nbsp; للرصد المنتظم من قبل الطبيب. وهذا أمر ضروري وخصوصا في بداية العلاج، خلال زيادة الجرعة وعند التوقف عن العلاج</p><p>يؤخذ القرص مع بعض الماء في الصباح، مع او دون الطعام. لا تسحق أو تمضغ القرص. يمكن تقسيم الأقراص إلى جرعتين بالتساوي</p><p>العلاج مع اوبسول&nbsp; عادة ما يكون طويل المدى</p><p><strong>&nbsp;:البالغين بما في ذلك كبار السن</strong></p><p>يجب أن يبدأ العلاج مع بيسوبرولول بجرعة منخفضة وتزداد تدريجيا</p><p>&nbsp;:طبيبك سوف يقرر كيفية زيادة الجرعة، وعادة ما يتم ذلك بالطريقة التالية</p><p>- 1.25 ملغم بيسوبرولول مرة واحدة يوميا لمدة أسبوع واحد</p><p>- 2.5 ملغم بيسوبرولول مرة واحدة يوميا لمدة أسبوع واحد</p><p>- 3.75 ملغم بيسوبرولول مرة واحدة يوميا لمدة أسبوع واحد</p><p>- 5 ملغم&nbsp; بيسوبرولول مرة واحدة يوميا لمدة أربعة أسابيع</p><p>- 7.5 ملغم بيسوبرولول مرة واحدة يوميا لمدة أربعة أسابيع</p><p>- 10 ملغم مرة واحدة يوميا بيسوبرولول للجرعة الاستمرارية (مستمر) العلاج</p><p>الحد الأقصى الموصى به من الجرعة اليومية هي 10 ملغم من بيسوبرولول</p><p>&nbsp;</p><p>اعتمادا على مدى تقبل الدواء، فإن طبيبك قد يقرر أيضا إلى إطالة الوقت بين زيادة الجرعة. إذا ساءت حالتك أو لم تعد تتحمل الدواء، قد يكون من الضروري خفض الجرعة مرة أخرى أو الانقطاع عن العلاج. في بعض المرضى قد تكون الجرعة الاستمرارية أقل من 10 ملغم من بيسوبرولول كافية</p><p>طبيبك سوف يقول لكم ما يجب القيام به</p><p>إذا كان يجب عليك وقف العلاج تماما، فإن الطبيب عادة ما ينصحك بتقليل الجرعة تدريجيا، وإلا حالتك قد تصبح أسوأ</p><p><strong>إذا تناولت اوبسول&nbsp; أكثر مما يجب</strong></p><p>إذا تناولت من غير قصد جرعة أكثر من الموصوفة، أخبر طبيبك فورا. طبيبك سوف يقرر ما هي التدابير اللازمة</p><p>ويمكن أن تشمل أعراض فرط الجرعة تباطأ معدل ضربات القلب، صعوبة شديدة في التنفس، والشعور بالدوار، رجفان (بسبب انخفاض السكر في الدم)</p><p><strong>إذا نسيت تناول اوبسول&nbsp;</strong></p><p>لا تأخذ جرعة مضاعفة لتعويض الجرعة المنسية. خذ الجرعة المعتادة في صباح اليوم التالي</p><p><strong>إذا توقفت عن تناول اوبسول&nbsp;&nbsp;</strong></p><p>لا تتوقف عن تناول اوبسول&nbsp;&nbsp; إلا بناء على نصيحة الطبيب. وإلا فان حالتك قد تصبح أسوأ من ذلك بكثير</p><p>&nbsp;</p><p>إذا كان لديك أي أسئلة أخرى عن استعمال هذا الدواء، اسأل طبيبك، أو الصيدلاني</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، فإن اوبسول&nbsp;&nbsp; يمكن أن يتسبب في إحداث آثار جانبية، على الرغم من أن الجميع لا يصاب بها</p><p>لمنع حدوث الاثار الجانبية الخطيرة، يجب التحدث الى الطبيب فورا إذا كان الأثر الجانبي شديد، وقع فجأة أو ساء بسرعة</p><p>:ترتبط الآثار الجانبية الأكثر خطورة على وظيفة القلب</p><p>تباطؤ معدل ضربات القلب (قد يؤثر على أكثر من شخص في كل 10 اشخاص)</p><p>تفاقم فشل القلب (قد يؤثر حتى شخص في كل 10 اشخاص)</p><p>بطء أو عدم انتظام ضربات القلب (قد يؤثر على ما يصل إلى شخص في كل 100 شخص)</p><p>إذا كنت تشعر بالدوار أو الضعف، أو لديك صعوبات في التنفس يرجى الاتصال بطبيبك في أقرب وقت ممكن</p><p>&nbsp;</p><p>:هناك أثارا جانبية اخرى مذكورة ادناه مع تبيان تواتر حدوثها</p><p><strong>شائعة: (التي تؤثر على أقل من شخص في كل 10 أشخاص)</strong></p><p>التعب، والشعور بالضعف والدوار والصداع</p><p>الشعور بالبرد أو خدر في اليدين و / أو القدمين</p><p>انخفاض ضغط الدم</p><p>مشاكل في المعدة أو الأمعاء مثل الغثيان، والتقيؤ، والإسهال، أو الإمساك</p><p><strong>غير شائعة: (التي تؤثر على أقل من شخص في كل 100 شخص)</strong></p><p>اضطرابات النوم</p><p>الاكتئاب</p><p>الدوار عند الوقوف</p><p>صعوبة في التنفس في المرضى الذين يعانون من الربو أو أمراض الرئة المزمنة</p><p>ضعف في العضلات، وتشنجات</p><p><strong>نادرة: (التي قد تؤثر على أقل من شخص في كل 1000 شخص)</strong></p><p>ضعف السمع</p><p>سيلان الأنف التحسسي</p><p>انخفاض تدفق الدموع</p><p>التهاب الكبد، مما يتسبب في حدوث اصفرار الجلد وبياض العينين</p><p>اختلاف بعض نتائج فحص الدم لوظائف الكبد أو مستويات الدهون</p><p>ردود فعل تحسسية مثل الحكة والاحمرار والطفح الجلدي</p><p>اختلال الانتصاب</p><p>الكوابيس والهلوسة</p><p>الإغماء</p><p><strong>نادرة جدا: (التي تؤثر على أقل من شخص في كل 10000 أشخاص)</strong></p><p>تهيج واحمرار العين (التهاب الملتحمة)</p><p>تساقط الشعر</p><p>مظهر أو تفاقم الطفح الجلد الخشن (الصدفية)؛ الطفح الجلدي مثل الصدفية</p><p>إذا أصبحت أي من هذه الآثار الجانبية خطيرة، أو إذا لاحظت أي آثار جانبية غير المذكورة في هذه النشرة، يرجى إخبار الطبيب أو الصيدلاني</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ بعيدا عن متناول وبصر الأطفال</p><p>يحفظ في درجة حرارة لا تتجاوز 30 &deg;م</p><p>لا تستعمل اوبسول بعد تاريخ انتهاء الصلاحية التي توضع على العلبة الخارجية. يشير تاريخ الانتهاء إلى اليوم الأخير من ذلك الشهر</p><p>يجب عدم التخلص من الأدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلاني عن كيفية التخلص من الأدوية التي لم تعد مطلوبة. وسوف تساعد هذه التدابير في حماية البيئة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة هي بيسوبرولول فيوماريت</p><p>اوبسول&nbsp; 5ملغم أقراص مغلفة: كل قرص مغلف يحتوي على بيسوبرولول فيوماريت 5 ملغم</p><p>اوبسول&nbsp; 10ملغم أقراص مغلفة:&nbsp; كل قرص مغلف يحتوي على بيسوبرولول فيوماريت 10 ملغم</p><p>عبوات المستشفيات متوفرة أيضا</p><p>&nbsp;</p><p>المكونات الأخرى هي</p><p>اوبسول&nbsp; 5ملغم أقراص مغلفة: فوسفات ثنائي الكالسيوم القاعدي، ميكروكريستالاين السيلليلوز، نشا، كروسبوفيدون، ماغنيسيوم ستيريت، هيدروكسي بروبيل ميثيل سيلليلوز، أوكسيد الحديد الأصفر</p><p>اوبسول 10ملغم أقراص مغلفة: فوسفات ثنائي الكالسيوم القاعدي، ميكروكريستالاين السيلليلوز، نشا، كروسبوفيدون، ماغنيسيوم ستيريت ، هيدروكسي بروبيل ميثيل سيلليلوز، أوكسيد الحديد الأحمر، أوكسيد الحديد الأصفر</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            أقراص مغلفة. 
الوصف الخارجي:
اوبسول   5 ملغم أقراص مغلفة: أقراص مغلفة ذات لون بيج على شكل قلب ثنائي التحدب، منقوشة بـ "I 42" قابلة للقسمة من كلا الجانبين.
اوبسول   10 ملغم أقراص مغلفة: أقراص مغلفة ذات لون بني فاتح على شكل قلب قابلة للقسمة من كلا الجانبين منقوشة بـ " T 32" على احد الجوانب وفارغة على الجنب الأخر.
اوبسول   أقراص مغلفة: معبأة في أشرطة من الألومنيوم والبلاستيك نوع PVC/PE /PVDC ثم معبأة في صناديق من الورق المقوى مع نشرة مطوية.
حجم العبوة: يتوفر في عبوات سعة 30 قرص (10 أقراص/شريط، 3 أشرطة/عبوة)

        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>إم إس فارما السعودية</p><p>الرياض ، المملكة العربية السعودية</p><p>info-ksa@mspharma.com</p><p>صنعت بواسطة :&nbsp;&nbsp;</p><p>المتحدة للصناعات الدوائية - الأردن لصالح إم إس فارما &ndash; المملكة العربية السعودية</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            فبراير/2020؛ رقم النسخة : SPM190336


        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Obsol® 5mg Film Coated Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Material Name	Amount / one Tablet (mg)
Bisoprolol Fumarate	5.15
Dibasic calcium phosphate	102.00
Microcrystalline cellulose	47.55
Maiz starch	8.50
Crospovidone	5.10
Magnesium stearate	1.70
Total	170.00
Hydroxy propyl methylcellulose	~5.0
Yellow iron oxide	

For a full list of excipients, see section 6.1 


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated Tablets
Obsol® 5mg F.C. Tablets: Heart-shaped beige biconvex film coated tablet, embossed with “I42” and scored at the both side.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment of stable chronic heart failure with reduced systolic left ventricular function in addition to ACE inhibitors, and diuretics, and optionally cardiac glycosides</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Route of administration: Orally.</p><p>Standard treatment of CHF consists of an ACE inhibitor (or an angiotensin receptor blocker in case of intolerance to ACE inhibitors), a beta-blocker, diuretics, and when appropriate cardiac glycosides. Patients should be stable (without acute failure) when bisoprolol treatment is initiated.</p><p>It is recommended that the treating physician should be experienced in the management of chronic heart failure.</p><p>Transient worsening of heart failure, hypotension, or bradycardia may occur during the titration period and thereafter.</p><p><u>Posology</u></p><p><em>Titration phase</em></p><p>The treatment of stable chronic heart failure with bisoprolol requires a titration phase</p><p>The treatment with bisoprolol is to be started with a gradual up titration according to the following steps:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.25 mg once daily for 1 week, if well tolerated increase to</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.5 mg once daily for a further week, if well tolerated increase to</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.75 mg once daily for a further week, if well tolerated increase to</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5 mg once daily for the 4 following weeks, if well tolerated increase to</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7.5 mg once daily for the 4 following weeks, if well tolerated increase to</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10 mg once daily for the maintenance therapy.</p><p>The maximum recommended dose is 10 mg once daily.</p><p>Close monitoring of vital signs (heart rate, blood pressure) and symptoms of worsening heart failure is recommended during the titration phase. Symptoms may already occur within the first day after initiating the therapy.</p><p><em>Treatment modification</em></p><p>If the maximum recommended dose is not well tolerated, gradual dose reduction may be considered.</p><p>In case of transient worsening of heart failure, hypotension, or bradycardia reconsideration of the dosage of the concomitant medication is recommended. It may also be necessary to temporarily lower the dose of bisoprolol or to consider discontinuation.</p><p>The reintroduction and/or up titration of bisoprolol should always be considered when the patient becomes stable again.</p><p>If discontinuation is considered, gradual dose decrease is recommended, since abrupt withdrawal may lead to acute deterioration of the patient&rsquo;s condition.</p><p>Treatment of stable chronic heart failure with bisoprolol is generally a long-term treatment.</p><p><em>Patients with hepatic or renal impairment</em></p><p>There is no information regarding pharmacokinetics of bisoprolol in patients with chronic heart failure and with impaired hepatic or renal function. Up titration of the dose in these populations should therefore be made with additional caution.</p><p><em>Older people</em></p><p>No dosage adjustment is required.</p><p><em>Paediatric population</em></p><p>There is no paediatric experience with bisoprolol, therefore its use cannot be recommended in paediatric patients.</p><p><u>Method of administration</u></p><p>Bisoprolol tablets should be taken in the morning and can be taken with food. They should be swallowed with liquid and should not be chewed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Bisoprolol is contraindicated in chronic heart failure patients with:
-	Acute heart failure or during episodes of heart failure decompensation requiring i.v. inotropic therapy
-	Cardiogenic shock
-	Second or third degree AV block
-	Sick sinus syndrome
-	Sinoatrial block
-	Symptomatic bradycardia
-	Symptomatic hypotension
-	Severe bronchial asthma
-	Severe forms of peripheral arterial occlusive disease or severe forms of Raynaud's syndrome
-	Untreated phaeochromocytoma 
-	Metabolic acidosis
-	Hypersensitivity to bisoprolol or to any of the excipients

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The treatment of stable chronic heart failure with bisoprolol has to be initiated with a special titration phase.</p><p>Especially in patients with ischaemic heart disease the cessation of therapy with bisoprolol must not be done abruptly unless clearly indicated, because this may lead to transitional worsening of heart condition.</p><p>The initiation and cessation of treatment with bisoprolol necessitates regular monitoring.</p><p>There is no therapeutic experience of bisoprolol treatment of heart failure in patients with the following diseases and conditions:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Insulin dependent diabetes mellitus (type I)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severely impaired renal function</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severely impaired hepatic function</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Restrictive cardiomyopathy</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Congenital heart disease</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hemodynamically significant organic valvular disease</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Myocardial infarction within 3 months</p><p>Bisoprolol must be used with caution in:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bronchospasm (bronchial asthma, obstructive airways diseases)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diabetes mellitus with large fluctuations in blood glucose values; Symptoms of hypoglycaemia can be masked</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Strict fasting</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ongoing desensitisation therapy. As with other beta-blockers, bisoprolol may increase both the sensitivity towards allergens and the severity of anaphylactic reactions. Epinephrine treatment does not always yield the expected therapeutic effect.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; First degree AV block</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prinzmetal&#39;s angina</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Peripheral arterial occlusive disease. Aggravation of symptoms may occur especially when starting therapy.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; General anaesthesia</p><p>In patients undergoing general anaesthesia beta-blockade reduces the incidence of arrhythmias and myocardial ischemia during induction and intubation, and the post-operative period. It is currently recommended that maintenance beta-blockade be continued peri-operatively. The anesthetist must be aware of beta-blockade because of the potential for interactions with other drugs, resulting in brady-arrhythmias, attenuation of the reflex tachycardia and the decreased reflex ability to compensate for blood loss. If it is thought necessary to withdraw beta-blocker therapy before surgery, this should be done gradually and completed about 48 hours before anaesthesia.</p><p>Combination of bisoprolol with calcium antagonists of the verapamil or diltiazem type, with Class I antiarrhythmic drugs and with centrally acting antihypertensive drugs is generally not recommended.</p><p>&nbsp;</p><p>Although cardio selective (beta1) beta-blockers may have less effect on lung function than non-selective beta-blockers, as with all beta-blockers, these should be avoided in patients with obstructive airways diseases, unless there are compelling clinical reasons for their use. Where such reasons exist, Bisoprolol may be used with caution. In patients with obstructive airways diseases, the treatment with bisoprolol should be started at the lowest possible dose and patients should be carefully monitored for new symptoms (e.g. dyspnea, exercise intolerance, coughs). In bronchial asthma or other chronic obstructive lung diseases, which may cause symptoms, bronchodilating therapy should be given concomitantly. Occasionally an increase of the airway resistance may occur in patients with asthma, therefore the dose of beta<sub>2</sub>-stimulants may have to be increased.</p><p>Patients with psoriasis or with a history of psoriasis should only be given beta-blockers (e.g. bisoprolol) after carefully balancing the benefits against the risks.</p><p>In patients with phaeochromocytoma bisoprolol must not be administered until after alpha-receptor blockade.</p><p>Under treatment with bisoprolol the symptoms of a thyrotoxicosis may be masked.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Combinations not recommended</u></p><p>Calcium antagonists of the verapamil type and to a lesser extent of the diltiazem type: Negative influence on contractility and atrio-ventricular conduction. Intravenous administration of verapamil in patients on &beta;-blocker treatment may lead to profound hypotension and atrioventricular block.</p><p>Class I antiarrhythmic drugs (e.g. quinidine, disopyramide; lidocaine, phenytoin; flecainide, propafenone): Effect on atrio-ventricular conduction time may be potentiated and negative inotropic effect increased.</p><p>Centrally acting antihypertensive drugs such as clonidine and others (e.g. methyldopa, moxonodine, rilmenidine): Concomitant use of centrally acting antihypertensive drugs may worsen heart failure by a decrease in the central sympathetic tonus (reduction of heart rate and cardiac output, vasodilation). Abrupt withdrawal, particularly if prior to beta-blocker discontinuation, may increase risk of &ldquo;rebound hypertension&rdquo;.</p><p><u>Combinations to be used with caution</u></p><p>Calcium antagonists of the dihydropyridine type such as felodipine and amlodipine: Concomitant use may increase the risk of hypotension, and an increase in the risk of a further deterioration of the ventricular pump function in patients with heart failure cannot be excluded.</p><p>Class-III antiarrhythmic drugs (e.g. amiodarone): Effect on atrio-ventricular conduction time may be potentiated.</p><p>Topical beta-blockers (e.g. eye drops for glaucoma treatment) may add to the systemic effects of bisoprolol.</p><p>Parasympathomimetic drugs: Concomitant use may increase atrio-ventricular conduction time and the risk of bradycardia.</p><p>Insulin and oral antidiabetic drugs: Increase of blood sugar lowering effect. Blockade of beta-adrenoreceptors may mask symptoms of hypoglycaemia.</p><p>Anesthetic agents: Attenuation of the reflex tachycardia and increase of the risk of hypotension (for further information on general anaesthesia.</p><p>Digitalis glycosides: Reduction of heart rate, increase of atrio-ventricular conduction time.</p><p>Non-steroidal anti-inflammatory drugs (NSAIDs): NSAIDs may reduce the hypotensive effect of bisoprolol.</p><p>&Beta;-Sympathomimetic agents (e.g. isoprenaline, dobutamine): Combination with bisoprolol may reduce the effect of both agents.</p><p>Sympathomimetics that activate both &beta;- and &alpha;-adrenoceptors (e.g. noradrenaline, adrenaline): Combination with bisoprolol may unmask the &alpha;-adrenoceptors-mediated vasoconstrictor effects of these agents leading to blood pressure increase and exacerbated intermittent claudication. Such interactions are considered to be more likely with nonselective &beta;-blockers.</p><p>Concomitant use with antihypertensive agents as well as with other drugs with blood pressure lowering potential (e.g. tricyclic antidepressants, barbiturates, phenothiazines) may increase the risk of hypotension.</p><p><u>Combinations to be considered</u></p><p>Mefloquine: increased risk of bradycardia</p><p>Monoamine oxidase inhibitors (except MAO-B inhibitors): Enhanced hypotensive effect of the beta-blockers but also risk for hypertensive crisis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>Bisoprolol has pharmacological effects that may cause harmful effects on pregnancy and/or the fetus/newborn. In general, beta-adrenoceptors blockers reduce placental perfusion, which has been associated with growth retardation, intrauterine death, abortion or early labour. Adverse effects (e.g. hypoglycaemia and bradycardia) may occur in the fetus and newborn infant. If treatment with beta-adrenoceptors blockers is necessary, beta<sub>1</sub>-selective adrenoceptors blockers are preferable.</p><p>Bisoprolol should not be used during pregnancy unless clearly necessary. If treatment with bisoprolol is considered necessary, the utero-placental blood flow and the fetal growth should be monitored. In case of harmful effects on pregnancy or the fetus alternative treatment should be considered. The newborn infant must be closely monitored. Symptoms of hypoglycaemia and bradycardia are generally to be expected within the first 3 days.</p><p><u>Breast-feeding</u></p><p>It is not known whether this drug is excreted in human milk. Therefore, breastfeeding is not recommended during administration of bisoprolol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In coronary heart disease patients bisoprolol did not impair driving performance. However, due to individual variations in reactions to the drug, the ability to drive a vehicle or to operate machinery may be impaired. This should be considered particularly at start of treatment and upon change of medication as well as in conjunction with alcohol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following definitions apply to the frequency terminology used hereafter:</p><p>Very common (&ge; 1/10)</p><p>Common (&ge; 1/100 to &lt; 1/10)</p><p>Uncommon (&ge; 1/1,000 to &lt; 1/100)</p><p>Rare (&ge; 1/10,000 to &lt; 1/1,000)</p><p>Very rare (&lt; 1/10,000)</p><p>Frequency not known (cannot be estimated from available data)</p><table border="0" cellspacing="0" cellpadding="0" style="width:682px"><tbody><tr><td colspan="2" style="vertical-align:top"><p><u>Cardiac disorders:</u></p></td></tr><tr><td style="vertical-align:top"><p>Very common:</p></td><td style="vertical-align:top"><p>Bradycardia.</p></td></tr><tr><td style="vertical-align:top"><p>Common:</p></td><td style="vertical-align:top"><p>Worsening of heart failure.</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon:</p></td><td style="vertical-align:top"><p>AV-conduction disturbances.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Investigations:</u></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Increased triglycerides increased liver enzymes (ALAT, ASAT).</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Nervous system disorders:</u></p></td></tr><tr><td style="vertical-align:top"><p>Common:</p></td><td style="vertical-align:top"><p>Dizziness, headache.</p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Syncope</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Eye disorders:</u></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Reduced tear flow (to be considered if the patient uses lenses).</p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Conjunctivitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Ear and labyrinth disorders:</u></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Hearing disorders.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Respiratory, thoracic and mediastinal disorders:</u></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon:</p></td><td style="vertical-align:top"><p>Bronchospasm in patients with bronchial asthma or a history of obstructive airways disease.</p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Allergic rhinitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Gastrointestinal disorders:</u></p></td></tr><tr><td style="vertical-align:top"><p>Common:</p></td><td style="vertical-align:top"><p>Gastrointestinal complaints such as nausea, vomiting, diarrhoea, constipation.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Skin and subcutaneous tissue disorders:</u></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Hypersensitivity reactions (itching, flush, rash).</p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Alopecia. Beta-blockers may provoke or worsen psoriasis or induce psoriasis-like rash</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Musculoskeletal and connective tissue disorders:</u></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon:</p></td><td style="vertical-align:top"><p>Muscular weakness and cramps.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Vascular disorders:</u></p></td></tr><tr><td style="vertical-align:top"><p>Common:</p></td><td style="vertical-align:top"><p>Feeling of coldness or numbness in the extremities, hypotension.</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon:</p></td><td style="vertical-align:top"><p>Orthostatic hypotension.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>General disorders:</u></p></td></tr><tr><td style="vertical-align:top"><p>Common:</p></td><td style="vertical-align:top"><p>Asthenia, fatigue.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Hepatobiliary disorders:</u></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Hepatitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Reproductive system and breast disorders:</u></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Potency disorders.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><u>Psychiatric disorders:</u></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon:</p></td><td style="vertical-align:top"><p>Sleep disorders, depression.</p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Nightmares, hallucinations.</p></td></tr></tbody></table><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Symptoms</u></p><p>With overdose (e.g. daily dose of 15 mg instead of 7.5 mg) third degree AV-block, bradycardia, and dizziness have been reported<strong>.&nbsp;</strong>In general the most common signs expected with overdosage of a beta-blocker are bradycardia, hypotension, bronchospasm, acute cardiac insufficiency and hypoglycaemia. To date a few cases of overdose (maximum: 2000 mg) with bisoprolol have been reported in patients suffering from hypertension and/or coronary heart disease showing bradycardia and/or hypotension; all patients recovered. There is a wide inter-individual variation in sensitivity to one single high dose of bisoprolol and patients with heart failure are probably very sensitive. Therefore it is mandatory to initiate the treatment of these patients with a gradual up titration according to the scheme given in section 4.2 &ldquo;Posology and method of administration&rdquo;.</p><p><u>Management</u></p><p>If overdose occurs, bisoprolol treatment should be stopped and supportive and symptomatic treatment should be provided. Limited data suggest that bisoprolol is hardly dialysable. Based on the expected pharmacologic actions and recommendations for other beta-blockers, the following general measures should be considered when clinically warranted.</p><p>Bradycardia: Administer intravenous atropine. If the response is inadequate, isoprenaline or another agent with positive chronotropic properties may be given cautiously. Under some circumstances, trans venous pacemaker insertion may be necessary.</p><p>Hypotension: Intravenous fluids and vasopressors should be administered. Intravenous glucagon may be useful.</p><p>AV block (second or third degree): Patients should be carefully monitored and treated with isoprenaline infusion or trans venous cardiac pacemaker insertion.</p><p>Acute worsening of heart failure: Administer IV diuretics, inotropic agents, vasodilating agents.</p><p>Bronchospasm: Administer bronchodilator therapy such as isoprenaline, beta<sub>2</sub>-sympathomimetic drugs and/or aminophylline.</p><p>Hypoglycaemia: Administer IV glucose.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Beta blocking agents, selective</p><p>ATC Code: C07AB07</p><p><u>Mechanism of action</u></p><p>Bisoprolol is a highly beta<sub>1</sub>-selective-adrenoceptor blocking agent, lacking intrinsic stimulating and relevant membrane stabilizing activity. It only shows low affinity to the beta<sub>2</sub>-receptor of the smooth muscles of bronchi and vessels as well as to the beta<sub>2</sub>-receptors concerned with metabolic regulation. Therefore, bisoprolol is generally not to be expected to influence the airway resistance and beta<sub>2</sub>-mediated metabolic effects. Its beta<sub>1</sub>-selectivity extends beyond the therapeutic dose range.</p><p>Clinical efficacy and safety</p><p>In patients<s> </s>included in NYHA class III and in NYHA class IV. They had stable symptomatic systolic heart failure (ejection fraction&nbsp;<u>&lt;</u>35%, based on echocardiography). Total mortality was reduced from.&nbsp; A decrease in sudden death and a reduced number of heart failure episodes requiring hospital admission was observed. Finally, a significant improvement of the functional status according to NYHA classification has been shown. During the initiation and titration of bisoprolol hospital admission due to bradycardia, hypotension and acute decompensation were observed bisoprolol can also be used in elderly chronic heart failure patients with mild to moderate disease.</p><p>Bisoprolol is also used for the treatment of hypertension and angina.</p><p>In acute administration in patients with coronary heart disease without chronic heart failure bisoprolol reduces the heart rate and stroke volume and thus the cardiac output and oxygen consumption. In chronic administration the initially elevated peripheral resistance decreases.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u></p><p>Bisoprolol is absorbed and has a biological availability of about 90% after oral administration.</p><p><u>Distribution</u></p><p>The distribution volume is 3.5 l/kg. The plasma protein binding of bisoprolol is about 30%.</p><p><u>Biotransformation and Elimination</u></p><p>Bisoprolol is excreted from the body by two routes. 50% is metabolised by the liver to inactive metabolites which are then excreted by the kidneys. The remaining 50% is excreted by the kidneys in an unmetabolised form. Total clearance is approximately 15 l/h. The half-life in plasma of 10-12 hours gives a 24 hour effect after dosing once daily.</p><p><u>Linearity</u></p><p>The kinetics of bisoprolol are linear and independent of age.</p><p><u>Special population</u></p><p>Since the elimination takes place in the kidneys and the liver to the same extent a dosage adjustment is not required for patients with impaired liver function or renal insufficiency. The pharmacokinetics in patients with stable chronic heart failure and with impaired liver or renal function has not been studied. In patients with chronic heart failure (NYHA stage III) the plasma levels of bisoprolol are higher and the half-life is prolonged compared to healthy volunteers. Maximum plasma concentration at steady state is 64<u>+</u>21 ng/ml at a daily dose of 10 mg and the half-life is 17<u>+</u>5 hours.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity or carcinogenicity. Like other beta-blockers, bisoprolol caused maternal (decreased food intake and decreased body weight) and embryo/fetal toxicity (increased incidence of resorption, reduced birth weight of the offspring, retarded physical development) at high doses but was not teratogenic.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Dibasic calcium phosphate</p></td></tr><tr><td style="vertical-align:top"><p>Microcrystalline cellulose</p></td></tr><tr><td style="vertical-align:top"><p>Maiz starch</p></td></tr><tr><td style="vertical-align:top"><p>Crospovidone</p></td></tr><tr><td style="vertical-align:top"><p>Magnesium stearate</p></td></tr><tr><td style="vertical-align:top"><p><strong>Total</strong></p></td></tr><tr><td style="vertical-align:top"><p>Hydroxy propyl methylcellulose</p></td></tr><tr><td style="vertical-align:top"><p>Yellow iron oxide</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 Years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Obsol<sup>&reg;</sup> 5mg F.C. Tablets: </strong>are packed in blisters (Aluminum &amp; PVC/PE /PVDC Rolls then packed in cardboard cartons with a folded leaflet.</p><p>Pack size: 30 F/C Tablets; (10 F/C Tablets /blister, 3 blisters/ pack).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused product or waste should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                MS Pharma-Saudi  
Almuraba Area
Prince Abdulaziz bin Musaid bin Jalawi Street
Mansour Alrusais Building - F1
Riyadh-KSA
Tel: 00966114010606
Fax: 00966114010606
E-mail: Albaraa.bahhari@mspharma.com


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                September, 2015
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>